Autolus Therapeutics
Autolus Therapeutics is a clinical-stage biopharmaceutical company focused on the development of next-generation programmed T cell therapies for the treatment of cancer. The company is headquartered in London, United Kingdom, and operates primarily in the field of oncology and immunology.
Brand Identity Data
HQ Country
United Kingdom
Founded
2014
EU Headquartered
No
EU Manufactured
No
Stock Exchange
Private
Repair / Recycling
No
Ethical Certifications
None verified
Verified on July 22, 2026